Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Borch

Showing results (281-290 of 295) with videos related to

Pageof 30
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|December 21, 2004
Studies of relationships between variation of the human G protein-coupled receptor 40 Gene and Type 2 diabetes and insulin releaseY H Hamid, H Vissing, B Holst, et al.
Diabetes/Metabolism Research and Reviews|December 29, 2016
Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetesD R Webb, F Zaccardi, M J Davies, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 18, 2011
Screening for type 2 diabetes. Lessons from the ADDITION-Europe studyM van den Donk, A Sandbaek, K Borch-Johnsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 10, 2015
Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trialL Tao, E C F Wilson, N J Wareham, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2014
Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trialJ A Black, S J Sharp, N J Wareham, et al.
American Journal of Human Biology : the Official Journal of the Human Biology Council|July 28, 2012
Cardiorespiratory fitness and physical activity in Luo, Kamba, and Maasai of rural KenyaD L Christensen, D Faurholt-Jepsen, M K Boit, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 25, 2012
Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trialR K Simmons, S J Sharp, A Sandbæk, et al.
Diabetologia|December 15, 2010
The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetesM Alssema, D Vistisen, M W Heymans, et al.
Diabetologia|November 17, 2007
The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetesT Sparsø, G Andersen, T Nielsen, et al.
International Journal of Obesity (2005)|June 7, 2006
Genetic analysis of the estrogen-related receptor alpha and studies of association with obesity and type 2 diabetesL H Larsen, C S Rose, T Sparsø, et al.
Pageof 30

Showing results (281-290 of 295) with videos related to

Sort By:
Pageof 30
Diabetic Medicine : a Journal of the British Diabetic Association|December 21, 2004
Studies of relationships between variation of the human G protein-coupled receptor 40 Gene and Type 2 diabetes and insulin releaseY H Hamid, H Vissing, B Holst, et al.
Diabetes/Metabolism Research and Reviews|December 29, 2016
Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetesD R Webb, F Zaccardi, M J Davies, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 18, 2011
Screening for type 2 diabetes. Lessons from the ADDITION-Europe studyM van den Donk, A Sandbaek, K Borch-Johnsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 10, 2015
Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trialL Tao, E C F Wilson, N J Wareham, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2014
Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trialJ A Black, S J Sharp, N J Wareham, et al.
American Journal of Human Biology : the Official Journal of the Human Biology Council|July 28, 2012
Cardiorespiratory fitness and physical activity in Luo, Kamba, and Maasai of rural KenyaD L Christensen, D Faurholt-Jepsen, M K Boit, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 25, 2012
Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trialR K Simmons, S J Sharp, A Sandbæk, et al.
Diabetologia|December 15, 2010
The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetesM Alssema, D Vistisen, M W Heymans, et al.
Diabetologia|November 17, 2007
The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetesT Sparsø, G Andersen, T Nielsen, et al.
International Journal of Obesity (2005)|June 7, 2006
Genetic analysis of the estrogen-related receptor alpha and studies of association with obesity and type 2 diabetesL H Larsen, C S Rose, T Sparsø, et al.
Pageof 30